Emeis (Orpea): the 2022 care-home allegations, state inspection report, criminal probes and restructuring
Emeis (Orpea): the 2022 care-home allegations, state inspection report, criminal probes and restructuring: a public-record watch file compiled by Falling Shares Intelligence from filings and exchange disclosures, as of 2026-11-09. In early 2022 a book accused Orpea of serious failings in its care homes; the state inspectorates found, in a report published in April 2022, that the group had mishandled care funding and reporting.
From the early-2022 allegations in a book on Orpea's care homes to a state inspection report, criminal investigations, a Caisse des Dépôts-led restructuring and the company's exit from its safeguard plan in February 2026.
Falling Shares Intelligence, Edited by Wung Thomas, Editor-in-Chief. As of .
Summary
- In early 2022 a book accused Orpea of serious failings in its care homes; the state inspectorates found, in a report published in April 2022, that the group had mishandled care funding and reporting.
- French prosecutors opened several inquiries; in June 2023 two former executives were placed in pre-trial detention and a third under judicial supervision in a case that followed company complaints.
- A restructuring led by the Caisse des Dépôts converted unsecured debt to equity in 2023; the company exited its safeguard plan early in February 2026.
Key figures
| Care funds set aside, 2018 | €20.1m (8.6% of the care allowance, per the state report) |
|---|---|
| Care-section charges without regulatory basis, 2017-2020 | €50.2m (Per the state report) |
| Debt before restructuring | About €9bn (Per a market report) |
| Caisse des Dépôts-led group stake | 50.18% (After the capital increases of December 2023) |
The allegations and the state report
State orders inspection after the book
After the publication of the journalist's book Les Fossoyeurs, the government ordered the social affairs and finance inspectorates (IGAS and IGF) to investigate Orpea on 1 February 2022. The company disputed the book's accusations. (1 Feb 2022)
IGAS and IGF report published
The 524-page report, delivered at the end of March 2022, found that Orpea set aside part of its care allowances (€20.1m in 2018, with €6.8m spent as the rules require), that its reports to regulators were unreliable, and that €50.2m of care-section charges in 2017 to 2020 had no regulatory basis. It also reported high staff turnover and malnutrition among residents. The public version was redacted for business secrecy. (5 Apr 2022)
Criminal inquiries
Insider-trading preliminary inquiry
The national financial prosecutor opened a preliminary inquiry into suspected insider dealing by the then chief executive over a share sale of €588,000 in July 2021, before the book's publication. The agency that handles Orpea's communications was searched. Orpea's shares later fell by nearly 70%. (Mar 2022)
Former executives detained in a case that followed company complaints
After complaints filed by Orpea in 2022, the Nanterre prosecutor said the former chief executive and former finance chief were placed in pre-trial detention and a former deputy chief executive under judicial supervision. The investigation covers breach of trust, fraud, aggravated misuse of corporate assets, organised money laundering and private corruption. (27 to 29 Jun 2023)
Restructuring and later events
Caisse des Dépôts-led group takes control
A restructuring with three capital increases left a group led by the Caisse des Dépôts, with MAIF, MACSF and CNP Assurances, holding 50.18%, unsecured creditors 48.84% and the public free float 0.98%. The group had carried about €9bn of debt. (19 Dec 2023)
Dispute over Swiss nursing-home sale
Tertianum said it filed legal proceedings after emeis decided not to complete the sale of its Swiss unit Senevita, which Tertianum said was signed on 12 December 2025 with all closing conditions met. Tertianum said emeis cited a change of strategy. (9 Apr 2026)
The company's position and exit from safeguard
Former chief executive denies insider dealing
The former chief executive rejected the insider-dealing accusation, saying the sale of about a third of his shares had nothing to do with the book and that the book had not raised any particular concern for the company. (4 Feb 2022)
Early exit from the safeguard plan
Emeis announced it had exited its accelerated safeguard plan early, with the Nanterre economic court validating the exit. For 2025 it reported revenue of €5.9bn and operating profit before rents (Ebitdar) of €872m. (20 Feb 2026)
Standard
This file compiles regulator and court documents, exchange filings, company statements and published reporting about Emeis S.A. (formerly Orpea). Allegations are attributed to those who made them. An investigation is not a charge, a charge is not a finding, and nothing here is a finding of wrongdoing unless a competent authority has made one. The company disputed the allegations when they were made and its current management has filed complaints against former executives; the former executives have the right to contest the allegations. Individuals are not named unless an official document names them and they are central; otherwise roles are used. This is news coverage for information only, not investment advice.
Right of reply
Emeis S.A. (formerly Orpea), and anyone named in a record cited here, can send corrections or comments to info@fallingshares.com (or directly to the Editor-in-Chief, Wung Thomas, at wungthomas@fallingshares.com). Material responses will be published alongside the relevant entry.